| Name | Title | Contact Details |
|---|
Humacyte, Inc. (Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. The Company develops and manufactures acellular tissues to treat a wide range of diseases, injuries and chronic conditions. Humacyte`s initial opportunity, a portfolio of human acellular vessels (HAVs), is currently in late-stage clinical trials targeting multiple vascular applications, including vascular trauma repair, arteriovenous access for hemodialysis, and peripheral arterial disease. Preclinical development is also underway in coronary artery bypass grafts, pediatric heart surgery, treatment of type 1 diabetes, and multiple novel cell and tissue applications. Humacyte`s 6mm HAVs for AV access for performing hemodialysis was the first product candidate to receive the FDA`s Regenerative Medicine Advanced Therapy (RMAT) expedited review designation, and the HAV technology received priority designation for the treatment of vascular trauma by the U.S. Secretary of Defense.
American Pain Consortium is a network of interventional pain management practices and pain focused ambulatory surgical centers that treat a variety of conditions, including chronic pain, recent injuries, and spine related disorders.
Diversified Radiology of Colorado is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Denver, CO. To find more information about Diversified Radiology of Colorado, please visit www.divrad.com
Foundation of New York State Nurses Inc is a Guilderland, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Carolina Health Centers is a Greenwood, SC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.